klacid tablet 250 mg
abbott laboratories (singapore ) private limited - clarithromycin - tablet, film coated - 250 mg - clarithromycin 250 mg
klacid 250mg film-coated tablets
mylan products limited - clarithromycin - coated tablet - clarithromycin 250 mg - antibacterials for systemic use
klacid 500mg film-coated tablets
mylan products limited - clarithromycin - coated tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid once daily
viatris limited - clarithromycin 500mg; ; ; - modified release tablet - 500 mg - active: clarithromycin 500mg excipient: citric acid ethanol hypromellose lactose monohydrate macrogol 400 macrogol 8000 magnesium stearate povidone purified talc purified water quinoline yellow sodium alginate sodium calcium alginate sorbic acid stearic acid titanium dioxide
klacid xl 500mg tab extended-release tablet
abbott laboratories, united kingdom - clarithromycin - extended-release tablet - 500 mg
klacid xl 500mg tab extended-release tablet
abbott laboratories, united kingdom - clarithromycin - extended-release tablet - 500 mg
klacid xl 500mg tab extended-release tablet
abbott laboratories, united kingdom - clarithromycin - extended-release tablet - 500 mg
advagraf xl tacrolimus 5 mg prolonged-release capsule blister pack
astellas pharma australia pty ltd - tacrolimus, quantity: 5 mg - capsule, modified release - excipient ingredients: lactose monohydrate; titanium dioxide; hypromellose; sodium lauryl sulfate; iron oxide red; magnesium stearate; iron oxide yellow; ethylcellulose; gelatin; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.
advagraf xl tacrolimus 1 mg prolonged-release capsule blister pack
astellas pharma australia pty ltd - tacrolimus, quantity: 1 mg - capsule, modified release - excipient ingredients: hypromellose; iron oxide yellow; gelatin; sodium lauryl sulfate; titanium dioxide; ethylcellulose; iron oxide red; magnesium stearate; lactose monohydrate; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.
advagraf xl tacrolimus 0.5 mg prolonged-release capsule blister pack
astellas pharma australia pty ltd - tacrolimus, quantity: 0.5 mg - capsule, modified release - excipient ingredients: iron oxide yellow; hypromellose; iron oxide red; titanium dioxide; lactose monohydrate; ethylcellulose; magnesium stearate; sodium lauryl sulfate; gelatin; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.